82
Views
1
CrossRef citations to date
0
Altmetric
Original

Identification of nuclear spliceosomal antigens targeted by NOD mouse antibodies following sodium iodide intake

, , , &
Pages 99-106 | Received 13 Sep 2005, Accepted 25 Jan 2006, Published online: 07 Jul 2009
 

Abstract

The non-obese diabetic (NOD) mouse spontaneously develops a range of autoreactive responses including an autoantibody response to nuclear antigens. As elevated dietary iodine has been shown to increase thyroid autoimmune pathology in NOD mice, the effect of sodium iodide (NaI) on the development of anti-nuclear antibodies (ANA) was assessed. Interestingly, the NaI symporter is expressed in both thyroid and salivary glands. Elevated dietary iodine was found to increase the percentage of male NOD mice developing autoantibodies. Specifically, the nuclear autoantibodies that develop in NOD mice were shown to target specific spliceosomal components. The target specificity of the autoantibodies was determined using recombinant spliceosomal proteins and shown to include U1A, U170K, U2B″, U2A′, as well as the Sm proteins D1, D2, and B. The autoantibody isotypes most consistently represented were IgG2a and IgG2b.

Abbreviations
SS=

Sjögrens syndrome

NaI=

sodium iodide

Abbreviations
SS=

Sjögrens syndrome

NaI=

sodium iodide

Acknowledgements

The authors would like to thank Drs Nicole Parish and Tina Rich for their critical reading of this manuscript and helpful discussions. We would also like to thank the BBSRC, the MRC, The Wellcome Trust, The Benzon Foundation and The Isaac Newton Trust for supporting this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.